Fully Automated Pipeline for the Detection and Segmentation of Non-Small Cell Lung Cancer (NSCLC) on CT Images
NCT ID: NCT04164186
Last Updated: 2020-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1043 participants
OBSERVATIONAL
2019-03-10
2020-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer
NCT06496360
Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence.
NCT06163846
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer
NCT05925738
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
NCT05925751
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subsequently, we will use the inter- and intra-observer variance from the clinical study in a simulation or modeling study. We also compare the time needed and the consistency in segmentations by the software to medical doctors performance.
Reliability and Agreement study:
Primary tumours of 25 lung cancer patients will be delineated by 6 segmentation experts.
1. Assess agreement between automatic segmentation and radiologists' segmentation The primary tumours of 25 patients will be manually segmented by the radiologists and automatically by the the tool. The time needed to perform this task and the reproducibility of the segmentation will be recorded. The degree of overlap between the ROs and the automatic contour will be assessed pairwise using the Dice coefficient.
2. Delination of tumours by the experts, assisted by the software tool For another 25 patients, the experts will be provided with an automatic delineation, performed by the tool. They have the possibility to adjust and validate it. The time needed will be recorded. The difference between the mean overlap fraction in the first situation (manual delineation of experts) and the second situation (delineation of experts+ software tool) will be assessed, using a multi-observer Dice coefficient.
3. Assessment of intra-observer variance The experts will repeat the segmentation of the lung tumours after 2 weeks. They will repeat the manual segmentation (n=25) and the semi-automatic segmentation (n=25). This will make it possible to assess the intra-observer variance in both situations.
4. Qualitative assessment of the experts' preferences using an in-house developed visualization toolbox.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Automatic detection and segmentation of NSCLC tumors
an automated deep learning detection and segmentation software for non-small cell lung cancer (NSCLC) that can automatically detect and segment tumors on CT scans and thus reduce the human variation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Availability of definite diagnosis
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Liege
OTHER
University Hospital RWTH Aachen University, Aachen, Germany.
UNKNOWN
Affiliated Zhongshan Hospital of Dalian University, 6 Jiefang street, Dalian 116001, China
UNKNOWN
University of California, San Francisco
OTHER
Maastricht University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Individual Participant Data Set
View DocumentDocument Type: Individual Participant Data Set
View DocumentDocument Type: Individual Participant Data Set
View DocumentOther Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ALSP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.